menu
    • menu

    Company profile for Belhaven Biopharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Established in 2021 in Raleigh, North Carolina, Belhaven secured initial funding from local angels and support from the North Carolina Biotechnology Center. This funding facilitated preliminary work on Nasdepi®, identifying a lead formulation and conducting confirmatory nonclinical studies. In the latter half of 2022, Belhaven marked a significant milestone by successfully concluding a pre-IND meeting with the U.S. FDA, confi...
    Established in 2021 in Raleigh, North Carolina, Belhaven secured initial funding from local angels and support from the North Carolina Biotechnology Center. This funding facilitated preliminary work on Nasdepi®, identifying a lead formulation and conducting confirmatory nonclinical studies. In the latter half of 2022, Belhaven marked a significant milestone by successfully concluding a pre-IND meeting with the U.S. FDA, confirming Nasdepi®'s development program requirements. Responding to this achievement, Belhaven expanded its team to navigate the transition from research to clinical development and to diversify its product portfolio.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Belhaven BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Research Triangle Park, NC 27709
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://belhavenbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/belhaven-biopharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Belhaven Biopharma Initiates a Pivotal Biocomparability Study
    Belhaven Biopharma Initiates a Pivotal Biocomparability Study

    08 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-08/belhaven-biopharma-initiates-a-pivotal-biocomparability-study-to-evaluate-the-pharmacokinetics-phar

    PHARMIWEB
    08 Oct 2025
    Share Share
    Belhaven Funds Nasdepi(R) Program's Development with Series A
    Belhaven Funds Nasdepi(R) Program's Development with Series A

    19 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-19/belhaven-biopharma-closes-oversubscribed-series-a-to-fund-the-development-of-nasdepi-r-program-move

    PHARMAWEB
    19 Aug 2025
    Share Share
    Belhaven Biopharma Reports Positive Nasdepi(R) Study Data
    Belhaven Biopharma Reports Positive Nasdepi(R) Study Data

    15 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/belhaven-biopharma-announces-positive-data-from-their-nasdepir-dose-c-1013470

    ACCESSWIRE
    15 Apr 2025
    Share Share
    Belhaven Biopharma Raises $11M To Advance Nasdepi® For Anaphylaxis
    Belhaven Biopharma Raises $11M To Advance Nasdepi® For Anaphylaxis

    22 Jan 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-01-21/belhaven-biopharma-raises-11m-to-advance-nasdepi-r-the-dry-powder-nasal-breakthrough-for-anaphyla-1

    PHARMAWEB
    22 Jan 2025
    Share Share
    Belhaven Biopharma To Reveal Nasdepi® Data At DDL 2024
    Belhaven Biopharma To Reveal Nasdepi® Data At DDL 2024

    11 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=953261&lang=en

    ACCESSWIRE
    11 Dec 2024
    Share Share
    Belhaven Biopharma Presents Phase 1 Data on Epinephrine Powder
    Belhaven Biopharma Presents Phase 1 Data on Epinephrine Powder

    24 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/932853/belhaven-biopharma-to-present-promising-phase-1-data-on-needle-free-epinephrine-powder-at-acaai-annual-meeting

    ACCESSWIRE
    24 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search